Trademark: 97166110
Status Date
Tuesday, May 7, 2024
Filing Date
Friday, December 10, 2021
Published for Opposition
Tuesday, March 15, 2022
5 Pharmaceutical preparations for the treatment of autoimmune and inflammatory diseases and disorders; Pharmaceutical preparations for the treatment of alopecia areata, vitiligo, inflammatory bowel disease, ulcerative colitis, and Crohn's disease
The mark consists of a design comprised of eight elongated diamond shapes of varying sizes and arranged in a circular pattern.
Color is not claimed as a feature of the mark.
Feb 3, 2022
Assigned To Examiner
Dec 14, 2021
New Application Entered
Dec 15, 2021
New Application Office Supplied Data Entered
Dec 16, 2021
Notice Of Design Search Code E-Mailed
Feb 4, 2022
Approved For Pub - Principal Register
Feb 23, 2022
Notification Of Notice Of Publication E-Mailed
Mar 15, 2022
Published For Opposition
Mar 15, 2022
Official Gazette Publication Confirmation E-Mailed
May 10, 2022
Noa E-Mailed - Sou Required From Applicant
Oct 17, 2022
Sou Teas Extension Received
Oct 17, 2022
Sou Extension 1 Filed
Oct 17, 2022
Sou Extension 1 Granted
Oct 19, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 28, 2023
Teas Change Of Owner Address Received
Mar 28, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 28, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 28, 2023
Teas Change Of Correspondence Received
Mar 28, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 23, 2023
Sou Teas Extension Received
Oct 23, 2023
Sou Extension 3 Filed
Oct 23, 2023
Sou Extension 3 Granted
Oct 25, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 17, 2023
Sou Teas Extension Received
Apr 17, 2023
Sou Extension 2 Filed
Apr 17, 2023
Sou Extension 2 Granted
Apr 19, 2023
Notice Of Approval Of Extension Request E-Mailed
May 7, 2024
Sou Extension 4 Filed
May 7, 2024
Sou Extension 4 Granted
May 7, 2024
Sou Teas Extension Received
May 8, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
